Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
XELOX for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dendritic Cell Based Therapy of Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen
- Status
- COMPLETED
- Phase
- PHASE2
Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers
- Status
- COMPLETED
- Phase
- PHASE1
An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine
- Status
- TERMINATED
- Phase
- PHASE2
Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Companion Pharmacogenetic Study to UMCC 9900/9901
- Status
- TERMINATED
- Phase
- N/A
Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
- Status
- COMPLETED
- Phase
- PHASE2
To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older
- Status
- TERMINATED
- Phase
- PHASE3
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3